Journal Article

Epithelial cell polarity and improved early outcomes in delayed graft function: a pilot study of polyclonal <i>vs</i> monoclonal antibodies

Yolanda T. Becker, R. Michael Hofmann, Joseph Yracheta, Andreas Friedl and Bryan N. Becker

in Nephrology Dialysis Transplantation

Published on behalf of European Renal Association - European Dialysis and Transplant Assoc

Volume 19, issue 11, pages 2886-2892
Published in print November 2004 | ISSN: 0931-0509
Published online November 2004 | e-ISSN: 1460-2385 | DOI: http://dx.doi.org/10.1093/ndt/gfh240
Epithelial cell polarity and improved early outcomes in delayed graft function: a pilot study of polyclonal vs monoclonal antibodies

Show Summary Details

Preview

Background. Polyclonal antibody preparations contain antibodies that bind not only to molecules on circulating lymphocytes but also to other sites that bear similar antigens. We hypothesized that this extra-antibody effect would increase the number of intact tubular epithelial cells in organs at high risk for delayed graft function (DGF).

Methods. We used immunohistochemistry to examine serial biopsy samples (time 0 and 7–10 days after transplantation) in 18 kidney transplant recipients with DGF. These individuals received either polyclonal rabbit antithymocyte sera or a monoclonal humanized anti-CD25 antibody as induction immunosuppression. We also examined their early clinical course over 6 months.

Results. Individuals treated with the polyclonal preparation demonstrated greater preservation of kidney epithelial cell polarity manifested by more intense and more localized basolateral distribution of E-cadherin (P = 0.016), β-catenin (P = 0.008) and Na-K ATPase (P = 0.02). These individuals were also more likely to maintain greater estimated glomerular filtration rates (eGFRs) at follow-up than patients treated with an anti-CD25 monoclonal antibody (6 month eGFR polyclonal: 55.5±7.12 ml/min vs monoclonal: 43.33±6.48 ml/min; P = 0.002).

Conclusion. Though a pilot study, these data suggest that a purified polyclonal antibody preparation may help conserve functional kidney mass during DGF with potential benefits on transplant function overall.

Keywords: antibody therapy; delayed graft function; epithelial polarity; kidney transplantation; transplant function

Journal Article.  3903 words.  Illustrated.

Subjects: Nephrology

Full text: subscription required

How to subscribe Recommend to my Librarian

Users without a subscription are not able to see the full content. Please, subscribe or login to access all content.